Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
Care for patients with human immunodeficiency virus (HIV) infection requires excellence in all aspects of family practice. The family physician’s roles include providing patient education to prevent uninfected persons from becoming infected, identifying and counseling infected persons, delivering comprehensive medical care (including antiretroviral treatment), prophylaxis against opportunistic infections, management of the acquired immunodeficiency syndrome (AIDS), and providing support and care for the family. New manifestations of HIV disease, diagnostic protocols, and drug recommendations for HIV disease1 change on a regular basis. Epidemiologic, social, and community trends also have important effects on clinical care.
KeywordsHuman Immunodeficiency Virus Human Immunodeficiency Virus Infection Pneumocystis Carinii Pneumonia Cryptococcal Meningitis Mycobacterium Avium Complex
Unable to display preview. Download preview PDF.
- 2.Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41 RR-17:1–19.Google Scholar
- 3.Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR 1990;39 RR-1:1–14.Google Scholar
- 4.Centers for Disease Control and Prevention. Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996;45:468–72.Google Scholar
- 5.Centers for Disease Control. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987;36:509–15.Google Scholar
- 7.Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989;38:236–8, 243–50.Google Scholar
- 8.Centers for Disease Control. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40 RR-5:27–33.Google Scholar
- 11.Centers for Disease Control and Prevention. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 1995;44 RR-8:1–34.Google Scholar
- 20.Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: the National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis carinii pneumonia. N Engl J Med 1990;323:1500–4.CrossRefGoogle Scholar
- 21.Centers for Disease Control. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR 1993;42 RR-7:1–8.Google Scholar
- 28.Centers for Disease Control and Prevention. Recommendations of the US Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994;43 RR-11:1–20.Google Scholar